Cytokine Launch Syndrome (CRS): CRS occurred in TZIELD-handled individuals through the procedure period and through 28 times once the last drug administration. Ahead of TZIELD treatment method, premedicate with antipyretics, antihistamines and/or antiemetics, and address similarly if indications